Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Benjamin G Barwick | |||||||
GSE246426 |
ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma [ATAC-seq]
|
16 | Benjamin G Barwick | Oct 30, 2023 | ||||
GSE246429 |
ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma [ChIP-seq]
|
20 | Benjamin G Barwick | Oct 30, 2023 | ||||
GSE246435 |
ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma [RNA-seq]
|
12 | Benjamin G Barwick | Oct 30, 2023 | ||||
GSE246436 |
ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma
|
48 | Benjamin G Barwick | Oct 29, 2023 | ||||
GSE243978 |
Transcriptional heterogeneity overcomes super-enhancer disrupting drug combinations in multiple myeloma [ATAC-seq]
|
8 | Benjamin G Barwick | Sep 25, 2023 | ||||
GSE243990 |
Transcriptional heterogeneity overcomes super-enhancer disrupting drug combinations in multiple myeloma [RNA-seq]
|
32 | Benjamin G Barwick | Sep 25, 2023 | ||||
GSE244002 |
Transcriptional heterogeneity overcomes super-enhancer disrupting drug combinations in multiple myeloma [ChIP-seq]
|
4 | Benjamin G Barwick | Sep 25, 2023 | ||||
GSE244003 |
Transcriptional heterogeneity overcomes super-enhancer disrupting drug combinations in multiple myeloma
|
44 | Benjamin G Barwick | Sep 25, 2023 | ||||
GSE167967 |
ATAC-seq of Multiple Myeloma
|
13 | Benjamin G Barwick | Mar 03, 2021 | ||||
GSE167968 |
RNA-seq of Multiple Myeloma
|
33 | Benjamin G Barwick | Mar 03, 2021 | ||||
GSE167969 |
ATAC-seq and RNA-Seq of Multiple Myeloma
|
46 | Benjamin G Barwick | Mar 03, 2021 | ||||
GSE121912 |
Multiple myeloma immunoglobulin lambda translocations portend poor prognosis
|
28 | Benjamin G Barwick | Mar 13, 2019 | ||||
GSE128024 |
ChIP-seq analysis of myeloma cell lines
|
5 | Benjamin G Barwick | Mar 13, 2019 | ||||
GSE89412 |
B cell differentiation is limited by de novo DNA methylation [RNA-seq]
|
18 | Benjamin G Barwick | Dec 31, 2017 | ||||
GSE89467 |
B cell differentiation is limited by de novo DNA methylation [RRBS]
|
18 | Benjamin G Barwick | Dec 31, 2017 | ||||
GSE89470 |
B cell differentiation is limited by de novo DNA methylation [ATAC-seq]
|
17 | Benjamin G Barwick | Dec 31, 2017 | ||||
GSE89471 |
B cell activation and plasma cell differentiation are inhibited by de novo DNA methylation
|
53 | Benjamin G Barwick | Dec 31, 2017 | ||||
GSE98875 |
LSD1 inhibition induces neurodegeneration and provides a common link to Alzheimer's disease and Frontotemporal dementia
|
4 | Benjamin G Barwick | May 13, 2017 | ||||
GSE89511 |
CD86 regulates a pro-survival signal in myeloma cells
|
16 | Benjamin G Barwick | Jan 01, 2017 | ||||
GSE79124 |
MOG KO Tregs versus WT Tregs
|
6 | Benjamin G Barwick | Aug 31, 2016 |